The ALBA Strategy Plan for the period 2017-2020 has been positively evaluated and approved by the Spanish Ministry of Science, Innovation and Universities.
Cerdanyola del Vallès, 24th January 2019. ALBA has published the last Strategy Plan of the facility that covers the period 2017-2020, which was positively evaluated by the CAIS (Comité Asesor de Infraestructuras Singulares) and approved by the Spanish Ministry of Science, Innovation and Universities last November 2018. The document has two different parts: an analysis of the performance of the facility in the previous period and a strategy plan with objectives, strategies and resources for the coming years.
The documents can be downloaded at the following links:
- 2017-2020 - Part I - Infrastructure Report, including a general description of the facility and fulfillment of ICTS requirements for the period 2013-2016.
- 2017-2020 - Part II - Strategy Plan, containing mission and vision statements, SWOT analysis and detailed description of the objectives, strategies and resources needed. The main objectives of the facility are: prioritising scientific research in four areas (drug design and biological process involving drugs, magnetic nanomaterials, catalysis and environmental sciences and energy-related materials), promoting technological developments as well as technology transfer, contributing to education for future researchers, expanding the international activity through new collaborations and preparing a long-term strategy for the facility.
